Literature DB >> 11037931

Cognitive status and relocation stress: a test of the vulnerability hypothesis.

J Mirotznik1, L L Kamp.   

Abstract

PURPOSE: This study investigated whether cognitively impaired nursing home residents are at particular risk of experiencing harmful effects during a mass, intra-institutional, interbuilding relocation. DESIGN AND METHODS: A pretest-post-test experimental-comparison group design was used. Data on cognitive status, functional capacity, psychosocial health status, physical health status, and mortality were abstracted from the Minimum Data Set Plus and were analyzed using continuous and discrete survival analyses, controlling for covariates as well as baseline status of outcome variables.
RESULTS: None of the Relocation x Cognitive Status interaction effects were significant. Relocation main effects indicated that movers in general were more likely than nonmovers to decline in physical health status. Evidence also emerged for a positive long-term effect of moving on psychosocial health status. IMPLICATIONS: These findings suggest cognitively impaired residents are not at unusual risk of harmful effects as a consequence of mass, interbuilding transfer. Given the significant relocation main effects, though, caution must be taken in moving cognitively impaired residents, as it should be in moving any residents.

Entities:  

Mesh:

Year:  2000        PMID: 11037931     DOI: 10.1093/geront/40.5.531

Source DB:  PubMed          Journal:  Gerontologist        ISSN: 0016-9013


  2 in total

1.  Geographic concentration and correlates of nursing home closures: 1999-2008.

Authors:  Zhanlian Feng; Michael Lepore; Melissa A Clark; Denise Tyler; David B Smith; Vincent Mor; Mary L Fennell
Journal:  Arch Intern Med       Date:  2011-01-10

2.  The impact of relocation stress on cognitively impaired and cognitively unimpaired long-term care residents.

Authors:  Kyrsten Costlow; Patricia A Parmelee
Journal:  Aging Ment Health       Date:  2019-08-30       Impact factor: 3.658

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.